Approvals/TGA/EXELON PATCH 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet

Approved

STANDARD

EXELON PATCH 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet

Approval Id: e2245cabe6c76797
Product Name: EXELON PATCH 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet
Artg Id: 133422
Artg Name: EXELON PATCH 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2008-03-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-03122-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03173-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e2245cabe6c76797

Type

Standard